Compare VICI & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VICI | DXCM |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.0B | 34.4B |
| IPO Year | 2017 | 2005 |
| Metric | VICI | DXCM |
|---|---|---|
| Price | $25.51 | $87.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 21 |
| Target Price | $33.75 | ★ $85.33 |
| AVG Volume (30 Days) | ★ 5.5M | 4.0M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 6.29% | N/A |
| EPS Growth | 1.95 | ★ 47.18 |
| EPS | ★ 1.30 | 1.15 |
| Revenue | ★ $4,006,116,000.00 | N/A |
| Revenue This Year | $4.47 | $14.46 |
| Revenue Next Year | $1.67 | $12.31 |
| P/E Ratio | ★ $19.77 | $77.93 |
| Revenue Growth | ★ 4.08 | N/A |
| 52 Week Low | $25.34 | $54.11 |
| 52 Week High | $33.65 | $92.59 |
| Indicator | VICI | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 40.94 | 58.96 |
| Support Level | N/A | $87.51 |
| Resistance Level | $27.45 | $92.59 |
| Average True Range (ATR) | 0.38 | 2.35 |
| MACD | -0.05 | -0.62 |
| Stochastic Oscillator | 19.61 | 41.54 |
VICI Properties Inc is a real estate investment trust based in the United States. It engaged in the business of owning and acquiring gaming, hospitality, wellness, entertainment and leisure destinations, subject to long-term triple net leases. It own nearly 93 experiential assets across a geographically portfolio consisting of nearly 54 gaming properties and nearly 39 other experiential properties across the United States and Canada, including Caesars Palace Las Vegas, MGM Grand and the Venetian Resort Las Vegas.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.